Cargando…
Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
Chronic kidney disease (CKD) is a major global health problem. Unless intensive intervention is initiated, some patients can rapidly progress to end-stage kidney disease. However, it is often difficult to predict renal outcomes using conventional laboratory tests in individuals with CKD. Therefore,...
Autores principales: | Tanabe, Katsuyuki, Sato, Yasufumi, Wada, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073618/ https://www.ncbi.nlm.nih.gov/pubmed/29937525 http://dx.doi.org/10.3390/ijms19071859 |
Ejemplares similares
-
Antiangiogenic Therapy for Diabetic Nephropathy
por: Tanabe, Katsuyuki, et al.
Publicado: (2017) -
Genetic Deletion of Vasohibin-2 Exacerbates Ischemia-Reperfusion-Induced Acute Kidney Injury
por: Miyake, Hiromasa, et al.
Publicado: (2020) -
Urine 5MedC, a Marker of DNA Methylation, in the Progression of Chronic Kidney Disease
por: Onishi, Akifumi, et al.
Publicado: (2019) -
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies
por: Pircher, Andreas, et al.
Publicado: (2016) -
Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease
por: Toba, Koji, et al.
Publicado: (2019)